Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Natalizumab-treated patients at high risk for PML persistently excrete JC polyomavirus.
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS).
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.
Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.
Analysis of MMP2-1306C/T and TIMP2G-418C polymorphisms with relapsing remitting multiple sclerosis.
Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.
Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman.
ANNALS EXPRESS: Multiple Sclerosis: Assay of Free Immunoglobulin Light Chains.
Papers: 5 Feb 2016 - 12 Feb 2016
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
MS Research Roundup: December 21, 2014
MAL Is a Regulator of the Recruitment of Myelin Protein PLP to Membrane Microdomains.
Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort: JC virus seroprevalence in Spain.
Multimodal evoked potentials follow up in multiple sclerosis patients under fingolimod therapy.
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Gut microbiota in early pediatric multiple sclerosis: a case-control study.
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United States.
Comparing Characteristics of Hungarian "Real Life" Patients With Participants of RCTS: First-Line Disease Modifying Therapies in Multiple Sclerosis.
PEGylated Interferon May Boost Efficacy, Reduce Side Effects
Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.
Sodium intake is associated with increased disease activity in multiple sclerosis.
An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.
MRI Clues Help Distinguish Neuromyelitis Optica From MS

Pages